
Swiss Clariant, a world leader in specialty chemicals, and Enviral, the largest producer of bioethanol in Slovakia, have signed a license agreement on sunliquid® cellulosic ethanol technology.

Swiss Clariant, a world leader in specialty chemicals, and Enviral, the largest producer of bioethanol in Slovakia, have signed a license agreement on sunliquid® cellulosic ethanol technology.
BioAmber has a new Chief Executive Officer. The Board of Directors of the renewable materials company based in Canada announced yesterday the appointment of Richard P. Eno as its new CEO and new member of the Board, effective September 18th, 2017. The selection of Eno caps a search process facilitated by Spencer Stuart, a global executive search firm which specializes in placing senior management personnel.

A New study conducted by nova-Institute and ordered by CropEnergies, which will be presented and discussed for the first time in Brussels on 26 September 2017, conducts quantitative and qualitative sustainability assessment of biofuels against the background of the EU’s REDII negotiations. This comprehensive sustainability assessment carried out by the German company led by Michael Caurs “shows that first generation bioethanol is as advantageous as second generation bioethanol for a feasible climate strategy”. According the nova-Institute “the results clearly indicate that the systematic discrimination against first generation biofuels of the current Commission proposal is in no way founded on scientific evidence. It would be counterproductive to further lower the share of first generation fuels in the EU’s energy mix”.

Bio-on and Kering Eyewear join forces to develop new materials based on Minerv PHAs, the revolutionary bioplastic which is 100% natural and biodegradable. “This is the first time in the world that a company in the eyewear industry has decided to carry out research with our biopolymers,” explains Marco Astorri, Chairman and CEO of Bio-on.
The chemical giant BASF and bse Engineering have signed an exclusive joint development agreement for BASF to provide custom made catalysts for a new chemical energy storage process. This process will enable economically viable transformation of excess current and off-gas carbon dioxide (CO2) into the chemical energy storage methanol in small-scale, delocalized production units.

Elopak, an international supplier of paper based packaging solutions for liquid food, based in Norway and wholly owned by the Ferd Group, and Stora Enso has launched the first gable top carton made from natural brown unbleached paperboard, creating the Naturally Pure-Pak® carton with a highly distinctive, natural look and feel.
Starting in July, the airport buses at Helsinki Airport has been fuelled by diesel manufactured wholly from waste and residue. Finavia – a limited corporation owned fully by the Finnish state, which is responsible for maintaining and developing its 21 airports and Finland’s air navigation system – started a gradual conversion to using renewable diesel in all buses travelling between the terminal and aircraft at Helsinki Airport. It is also Finavia’s goal to encourage other companies operating at its airports to use renewable fuels.
Ethanol Production Facility in Keyes, CACupertino-based Aemetis is producing cellulosic ethanol from orchard waste, utilizing technologies from Aemetis, LanzaTech and InEnTec, after successfully completing the construction and commencement of an Integrated Demonstration Unit.

Novozymes launched two new enzymes for the European ethanol market. The two products (Spirizyme® 2.0 T and Spirizyme Ultra T) are part of the Spirizyme T Portfolio, an advanced suite of glucoamylase enzymes with trehalase that deliver yield enhancing activities documented to provide the highest total sugar conversion in the industry.
Amyris, the U.S. industrial bioscience company led by John Melo, closed the second and final tranche of its previously announced financing. The second tranche of $50 million in a private placement was led by a $25 million investment from Koninklijke DSM N.V. (Royal DSM) with the remaining $25 million contributed by Vivo Capital.